LOREM THERAPEUTICS
Lorem Therapeutics is focusing on development early stage therapeutics in the phase between initial drug discovery and when a treatment begins review by the FDA for status as an Investigational New Drug. The company will use the funding “to accelerate and enhance our drug discovery efforts around critical cancer indications,” Slusher said in a statement.
LOREM THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Address:
Baltimore, Maryland, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Shifa Biomedical
Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.
Investors List
IP Group
IP Group investment in Seed Round - Lorem Therapeutics
Johns Hopkins Technology Ventures
Johns Hopkins Technology Ventures investment in Seed Round - Lorem Therapeutics
More informations about "Lorem Therapeutics"
Lorem Therapeutics - Crunchbase Company Profile & Funding
Lorem Tx is a drug discovery company translating innovative drugs from Johns Hopkins University. Lorem Therapeutics is focusing on development early stage therapeutics in the …See details»
Johns Hopkins-IP Group Collaboration Funds Cancer …
May 15, 2018 · Lorem will be focused on developing early-stage therapeutics, bridging the gap from drug discovery to investigative new drug (IND) status, specifically novel small molecule prodrugs for cancer indications.See details»
Lorem Therapeutics - Funding, Financials, Valuation & Investors
May 14, 2018 · Lorem Tx is a drug discovery company translating innovative drugs from Johns Hopkins University.See details»
Lorem Therapeutics - Products, Competitors, Financials, Employees ...
May 16, 2018 · Lorem Therapeutics will develop early-stage therapeutics for several cancer indications, with a specific focus on bridging the gap from drug discovery to Investigational …See details»
Lorem Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Lorem Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Lorem Pharmaceuticals Inc - Company Profile and News
Lorem Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company focuses on developing early-stage therapeutics for the treatment of cancer patients.See details»
Lorem_Therapeutics - Johns Hopkins Drug Discovery
The Johns Hopkins Drug Discovery Program, located in Baltimore, MD, works with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide …See details»
Lorem Pharmaceuticals Company Profile 2024: Valuation, Funding ...
Operator of a drug discovery company intended to research cancer treatment. The company's platform focuses on the research and development of drugs based on oncology, enabling …See details»
Lorem Therapeutics - Crunchbase
Lorem Therapeutics, Envoy Therapeutics, and Shifa Biomedical are focused on drug discovery and the development of innovative drugs for specific medical conditions. They are associated …See details»
Parexel and n-Lorem Foundation Partner to Support Development …
Feb 23, 2022 · One of the largest clinical research organizations, Parexel supports the development of innovative new medicines to improve the health of patients. We provide …See details»
n-Lorem Foundation Partners with Argonaut to Manufacture ASO …
Feb 2, 2022 · n-Lorem Foundation is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense …See details»
n-Lorem Has Industrialized the Treatment of Nano-rare Patients …
Jul 27, 2023 · SAN DIEGO-- ( BUSINESS WIRE )-- n-Lorem, a nonprofit foundation, outlines the steps the Foundation has taken to support the discovery, development and treatment of nano …See details»
Nutrasource Announces FDA Approval of Investigational New …
September 23, 2022: Guelph, ON – Nutrasource Pharmaceutical and Nutraceutical Services, a global full-service contract research organization (CRO) announced US FDA (Food and Drug …See details»
n-Lorem Provides Update on Its Remarkable Progress to Deliver …
Dec 19, 2023 · SAN DIEGO-- ( BUSINESS WIRE )-- n-Lorem, a nonprofit Foundation, outlines the exceptional progress the Foundation has made toward its mission to discover, develop and …See details»
n-Lorem Has Industrialized the Treatment of Nano-rare Patients …
SAN DIEGO, Calif., July 27, 2023, ( Business Wire) n-Lorem, a nonprofit foundation, outlines the steps the Foundation has taken to support the discovery, development and treatment of nano …See details»
Biotech millionaire funds free drugs for ultra-rare diseases - Nature
Jan 24, 2020 · The n-Lorem Foundation intends to form the connective tissue between patients, researchers, facilities and regulators needed to supply individual patients with RNA therapies …See details»
n-Lorem Foundation Announces Partnership with Nitto Avecia to ...
Jun 16, 2021 · n-Lorem Foundation is the first and only charitable organization with a mission to provide personalized and potentially life-saving treatments to patients who have diseases …See details»
Cytiva Continues its Support for n-Lorem Foundation
May 14, 2024 · The n-Lorem Foundation is a non-profit organization dedicated to addressing the therapeutic needs of nano-rare disease patients worldwide. These individuals, numbering …See details»
n-Lorem Foundation launches to develop individualized therapies …
Jan 8, 2020 · The nonprofit n-Lorem Foundation has launched with the goal of making it easier, safer, and cheaper to develop individualized antisense oligonucleotide therapies—sometimes …See details»